<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Munde M</submitter><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>847-64</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2988403</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>402(5)</volume><pubmed_abstract>With the increasing number and variations of genome sequences available, control of gene expression with synthetic, cell-permeable molecules is within reach. The variety of sequence-specific binding agents is, however, still quite limited. Many minor groove binding agents selectivity recognize AT over GC sequences but have less ability to distinguish among different AT sequences. The goal with this article is to develop compounds that can bind selectively to different AT sequences. A number of studies indicate that AATT and TTAA sequences have significantly different physical and interaction properties and different requirements for minor groove recognition. Although it has been difficult to get minor groove binding at TTAA, DB293, a phenyl-furan-benzimidazole diamidine, was found to bind </pubmed_abstract><journal>Journal of molecular biology</journal><pubmed_title>DNA minor groove induced dimerization of heterocyclic cations: compound structure, binding affinity, and specificity for a TTAA site.</pubmed_title><pmcid>PMC2988403</pmcid><funding_grant_id>AI064200</funding_grant_id><funding_grant_id>R01 AI064200</funding_grant_id><funding_grant_id>GM61587</funding_grant_id><funding_grant_id>R01 GM061587</funding_grant_id><pubmed_authors>Stephens CE</pubmed_authors><pubmed_authors>Batista-Parra A</pubmed_authors><pubmed_authors>David-Cordonnier MH</pubmed_authors><pubmed_authors>Ismail MA</pubmed_authors><pubmed_authors>Nhili R</pubmed_authors><pubmed_authors>Depauw S</pubmed_authors><pubmed_authors>Farahat AA</pubmed_authors><pubmed_authors>Boykin DW</pubmed_authors><pubmed_authors>Munde M</pubmed_authors><pubmed_authors>Kumar A</pubmed_authors><pubmed_authors>Wilson WD</pubmed_authors></additional><is_claimable>false</is_claimable><name>DNA minor groove induced dimerization of heterocyclic cations: compound structure, binding affinity, and specificity for a TTAA site.</name><description>With the increasing number and variations of genome sequences available, control of gene expression with synthetic, cell-permeable molecules is within reach. The variety of sequence-specific binding agents is, however, still quite limited. Many minor groove binding agents selectivity recognize AT over GC sequences but have less ability to distinguish among different AT sequences. The goal with this article is to develop compounds that can bind selectively to different AT sequences. A number of studies indicate that AATT and TTAA sequences have significantly different physical and interaction properties and different requirements for minor groove recognition. Although it has been difficult to get minor groove binding at TTAA, DB293, a phenyl-furan-benzimidazole diamidine, was found to bind </description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Oct</publication><modification>2025-04-05T00:26:11.617Z</modification><creation>2019-03-27T00:36:47Z</creation></dates><accession>S-EPMC2988403</accession><cross_references><pubmed>20713062</pubmed><doi>10.1016/j.jmb.2010.08.018</doi></cross_references></HashMap>